Adriana Burgy’s practice focuses on opinion work, client counseling, patent prosecution and management, and litigation in the chemical, pharmaceutical, and biotechnology arts. Adriana brings a unique perspective by blending her legal, technical, and industry experience.
Recognized by The Legal 500 U.S. for patent prosecution, re-examinations, and post-grant proceedings, Adriana counsels her clients on a diverse range of patent issues. She has managed the prosecution of hundreds of patent applications domestically and internationally directed to consumer products, pharmaceuticals, and small molecules. She assists clients on single-patent issues as well as complex matters involving multiple patents and applications requiring ongoing advice on patent portfolio strategy and development, with an eye towards litigation. Client counseling also comprises Adriana’s practice. She has assisted clients in the early stages of development through due diligence and patent portfolio analysis. Additionally, Adriana frequently counsels clients regarding prelitigation considerations.
From a patent prosecution perspective, Adriana has drafted and prosecuted numerous patent applications domestically and internationally, guided and advised clients on complex procedural and legal issues surrounding clients patent portfolios, developed and implemented strategic prosecution in support of ongoing litigation, generated strategies for maximizing investment in patent portfolios, and facilitated the identification of high-priority applications within patent portfolios. Adriana’s experience includes patentability searching, reexaminations, and reissues, and appeals to the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). With the changing landscape under the America Invents Act (AIA), Adriana has counseled clients to prepare for the historic reforms and to develop long-term strategies moving forward under this new regime. Adriana previously served as leader of Finnegan’s patent office practice.
Adriana routinely provides legal education and client seminars on various aspects of U.S. patent law and practice with a particular emphasis on practical tips and applications. She has presented on a range of topics, including patent application drafting, patent infringement, validity, and enforceability; restriction requirement practice; obviousness and the use of effective post-filing evidence; and various AIA topics.
More Legal and Business Bylines From Adriana L. Burgy
- The Virtues of Claiming Precisely What the FDA Approved! - (Posted On Monday, January 03, 2022)
- A Forgiving Response to a Candidly Admitted Error But Still Costly - (Posted On Friday, December 03, 2021)
- Bad Acts and Actors Never Die; They Simply Lose Their Appeal - (Posted On Friday, October 01, 2021)
- A Look at AIA § 3(n)(2): Part Two of a Two-Part Series on AIA § 3(n) Effective Filing Date Provisions - (Posted On Friday, September 24, 2021)
- Predictably Part 2: Merck Overcomes Obviousness Challenge at the PTAB - (Posted On Wednesday, September 22, 2021)
- Predictably, a Funny Thing Happened on the Way to the PTAB FWD - Part 1: Merck Overcomes Inherent Anticipation Challenge at the PTAB - (Posted On Tuesday, September 21, 2021)
- Pay the (PTO) Piper: Correct Erroneously Underpaid Maintenance Fees to Avoid Inequitable Conduct Challenges - (Posted On Friday, August 27, 2021)
- Coffee “or” Tea? Is That Coffee or Tea, but Not Both? Or Possibly Both? - (Posted On Friday, July 30, 2021)
- Punctuation Pitfalls: Commas and Periods Kill Patents - (Posted On Thursday, July 22, 2021)
- AIA § 3(n) Effective Filing Date Provisions Part I: A Look at PGR Eligibility - (Posted On Friday, July 16, 2021)